Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: PAL who wrote (4194)	5/4/1998 1:57:00 PM
From: Izzy	Read Replies (2) \| Respond to of 6136

Go up 50+ in one day. Does anyone have the time to call AGPH for current info on cancer drug (MMPI) pipeline? I can't call just now. What's amazing is that ENMD potential angiogenesis inhibitor chemical (sic, drug), couldn't possibly be on the market for some time. Yet, IGEN, PGEN have also gone up dramatically today. But it's AGPH who's making the big money now. It's about time it takes off again. IMO, Viracept will continue to be the primary PI with no significant competetion for a long, long time. Yet, PFE's Viagra is going to have a bunch of competitor drugs on the market in the near future. Yet, PFE keeps going up. Go figure...